Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient's selection.

ABSTRACT:

SUBMITTER: Gatto L 

PROVIDER: S-EPMC10809174 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature